Cite
MLA Citation
W. Rigby et al.. “THU0160 THE EFFECT OF HLA-DRB1 RISK ALLELES ON THE CLINICAL EFFICACY AND SAFETY OF ABATACEPT IN SEROPOSITIVE, BIOLOGIC-NAÏVE PATIENTS WITH EARLY, MODERATE-TO-SEVERE RA TREATED WITH ABATACEPT OR ADALIMUMAB: DATA FROM THE OPEN-LABEL SWITCH PERIOD OF THE HEAD-TO-HEAD SINGLE-BLINDED 'EARLY AMPLE' TRIAL.” Annals of the rheumatic diseases, vol. 79, n.d., p. 295. http://access.bl.uk/ark:/81055/vdc_100144726958.0x000046